| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| aprX | bprA | BL00903 | BL02252 | Alkaline serine protease; Belongs to the peptidase S8 family. | Bacillopeptidase F. | 0.440 |
| aprX | lanP | BL00903 | BL00930 | Alkaline serine protease; Belongs to the peptidase S8 family. | Intracellular serine protease; Belongs to the peptidase S8 family. | 0.733 |
| bprA | aprX | BL02252 | BL00903 | Bacillopeptidase F. | Alkaline serine protease; Belongs to the peptidase S8 family. | 0.440 |
| bprA | lanP | BL02252 | BL00930 | Bacillopeptidase F. | Intracellular serine protease; Belongs to the peptidase S8 family. | 0.736 |
| lanA | lanF | BL05375 | BL00934 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Lantibiotic immunity protein,ABC transporter. | 0.412 |
| lanA | lanG | BL05375 | BL00935 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Lantibiotic immunity protein, MFS type transporter. | 0.432 |
| lanA | lanM1 | BL05375 | BL00928 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Lantibiotic modifying enzyme. | 0.470 |
| lanA | lanM2 | BL05375 | BL00948 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Lantibiotic modifying enzyme. | 0.772 |
| lanA | lanP | BL05375 | BL00930 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Intracellular serine protease; Belongs to the peptidase S8 family. | 0.613 |
| lanA | lanR | BL05375 | BL00932 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Transcriptional regulator. | 0.613 |
| lanA | lanT | BL05375 | BL00929 | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | Lantibiotic transport protein. | 0.545 |
| lanF | lanA | BL00934 | BL05375 | Lantibiotic immunity protein,ABC transporter. | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | 0.412 |
| lanF | lanG | BL00934 | BL00935 | Lantibiotic immunity protein,ABC transporter. | Lantibiotic immunity protein, MFS type transporter. | 0.940 |
| lanF | lanM1 | BL00934 | BL00928 | Lantibiotic immunity protein,ABC transporter. | Lantibiotic modifying enzyme. | 0.638 |
| lanF | lanP | BL00934 | BL00930 | Lantibiotic immunity protein,ABC transporter. | Intracellular serine protease; Belongs to the peptidase S8 family. | 0.774 |
| lanF | lanR | BL00934 | BL00932 | Lantibiotic immunity protein,ABC transporter. | Transcriptional regulator. | 0.908 |
| lanF | lanT | BL00934 | BL00929 | Lantibiotic immunity protein,ABC transporter. | Lantibiotic transport protein. | 0.724 |
| lanF | lanX | BL00934 | BL00931 | Lantibiotic immunity protein,ABC transporter. | Conserved hypothetical protein. | 0.516 |
| lanG | lanA | BL00935 | BL05375 | Lantibiotic immunity protein, MFS type transporter. | Lichenicidin prepeptide; Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually, LchA1 exhibits activity towards L.lactis HP. When combined with LchA2, it displays activity towards a broad spectrum of non-pathogenic and pathogenic Gram-positive bacteria including strains of L.monocytogenes, methicillin-resistant S.aureus, S.pneumoniae and strains of vanco [...] | 0.432 |
| lanG | lanF | BL00935 | BL00934 | Lantibiotic immunity protein, MFS type transporter. | Lantibiotic immunity protein,ABC transporter. | 0.940 |